Intradermal, Naked Self-Replicating mRNA Vaccine Fails
With global use of Pfizer and Moderna mRNA vaccines, other companies have high aspirations for more products and record sales
The EXG-5003 vaccine was developed by Elixirgen Therapeutics, Inc. (Baltimore, MD, USA) as a strategy to inject a small quantity of naked mRNA in the skin with the hope that at lower skin temperature the mRNA would replicate and produce Spike protein but if absorbed into muscle or the bloodstream, the higher temperature would deactivate the product.
Given the horrific safety outcomes with the first generation and booster Pfizer and Moderna mRNA vaccines, the Elixirgen vaccine sounds too good to be true. Koseki et al essentially showed that the company’s concept failed.
In this small trial there were considerable systemic effects, suggesting the mRNA, Spike protein, and inflammatory factors or some combination thereof enters systemic circulation.
To make matters worse, the antibody responses against receptor binding domain of the Spike protein were unimpressive.
The trial broke down when subjects went ahead and took the commercial products while still being in the study.
The company’s website does not mention the trial or the potential for their product in COVID-19 vaccination.
No press release was issued on this study result.
This represents a tacit admission of failure kept silent in a time of hubris and wild spending on vaccine gene transfer technology.
See more here substack.com
Please Donate Below To Support Our Ongoing Work To Defend The Scientific Method
PRINCIPIA SCIENTIFIC INTERNATIONAL, legally registered in the UK as a company 
incorporated for charitable purposes. Head Office: 27 Old Gloucester Street, London WC1N 3AX.
Trackback from your site.
Tom
| #
Still waiting after 70 years for these clowns to do a study, just ONE comprehensive study that shows that having any vaccination/vaccines is better and healthier than not having any. Ever wonder why none have and never will be done by big pharma?
Reply
Wisenox
| #
Better make sure it doesn’t contain relaxin or adenoviruses. That combination is used to cross the blood brain barrier using micro-needle patch arrays. The relaxin assists the adenovirus through the interstitial tissue.
Reply